Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-072749
Filing Date
2020-06-12
Accepted
2020-06-12 11:56:12
Documents
2
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3872
2 EX-24 ex-24.htm EX-24 8540
  Complete submission text file 0001104659-20-072749.txt   13820
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARIAD PHARMACEUTICALS, INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Cole Hugh M (Reporting) CIK: 0001604646 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 20959482